8-64615112-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_004820.5(CYP7B1):​c.971G>A​(p.Arg324His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0367 in 1,613,552 control chromosomes in the GnomAD database, including 1,319 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R324G) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.027 ( 91 hom., cov: 32)
Exomes 𝑓: 0.038 ( 1228 hom. )

Consequence

CYP7B1
NM_004820.5 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 0.781

Publications

19 publications found
Variant links:
Genes affected
CYP7B1 (HGNC:2652): (cytochrome P450 family 7 subfamily B member 1) This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This endoplasmic reticulum membrane protein catalyzes the first reaction in the cholesterol catabolic pathway of extrahepatic tissues, which converts cholesterol to bile acids. This enzyme likely plays a minor role in total bile acid synthesis, but may also be involved in the development of atherosclerosis, neurosteroid metabolism and sex hormone synthesis. Mutations in this gene have been associated with hereditary spastic paraplegia (SPG5 or HSP), an autosomal recessive disorder. [provided by RefSeq, Apr 2016]
CYP7B1 Gene-Disease associations (from GenCC):
  • CYP7B1-related disorder of oxysterol accumulation
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • congenital bile acid synthesis defect 3
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet
  • hereditary spastic paraplegia 5A
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_004820.5, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.002134025).
BP6
Variant 8-64615112-C-T is Benign according to our data. Variant chr8-64615112-C-T is described in ClinVar as Benign. ClinVar VariationId is 363582.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAdExome4 highest subpopulation (MID) allele frequency at 95% confidence interval = 0.0573 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004820.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CYP7B1
NM_004820.5
MANE Select
c.971G>Ap.Arg324His
missense
Exon 4 of 6NP_004811.1O75881
CYP7B1
NM_001324112.2
c.971G>Ap.Arg324His
missense
Exon 4 of 7NP_001311041.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CYP7B1
ENST00000310193.4
TSL:1 MANE Select
c.971G>Ap.Arg324His
missense
Exon 4 of 6ENSP00000310721.3O75881
CYP7B1
ENST00000864436.1
c.1124G>Ap.Arg375His
missense
Exon 6 of 8ENSP00000534495.1
CYP7B1
ENST00000864435.1
c.971G>Ap.Arg324His
missense
Exon 5 of 7ENSP00000534494.1

Frequencies

GnomAD3 genomes
AF:
0.0275
AC:
4178
AN:
152016
Hom.:
91
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00676
Gnomad AMI
AF:
0.0252
Gnomad AMR
AF:
0.0258
Gnomad ASJ
AF:
0.0903
Gnomad EAS
AF:
0.000386
Gnomad SAS
AF:
0.0408
Gnomad FIN
AF:
0.0203
Gnomad MID
AF:
0.0696
Gnomad NFE
AF:
0.0393
Gnomad OTH
AF:
0.0302
GnomAD2 exomes
AF:
0.0343
AC:
8608
AN:
251132
AF XY:
0.0371
show subpopulations
Gnomad AFR exome
AF:
0.00578
Gnomad AMR exome
AF:
0.0212
Gnomad ASJ exome
AF:
0.0973
Gnomad EAS exome
AF:
0.000109
Gnomad FIN exome
AF:
0.0239
Gnomad NFE exome
AF:
0.0414
Gnomad OTH exome
AF:
0.0397
GnomAD4 exome
AF:
0.0377
AC:
55056
AN:
1461418
Hom.:
1228
Cov.:
32
AF XY:
0.0382
AC XY:
27789
AN XY:
727016
show subpopulations
African (AFR)
AF:
0.00550
AC:
184
AN:
33454
American (AMR)
AF:
0.0218
AC:
975
AN:
44658
Ashkenazi Jewish (ASJ)
AF:
0.0982
AC:
2566
AN:
26122
East Asian (EAS)
AF:
0.0000504
AC:
2
AN:
39694
South Asian (SAS)
AF:
0.0453
AC:
3911
AN:
86246
European-Finnish (FIN)
AF:
0.0236
AC:
1258
AN:
53376
Middle Eastern (MID)
AF:
0.0626
AC:
361
AN:
5768
European-Non Finnish (NFE)
AF:
0.0391
AC:
43488
AN:
1111742
Other (OTH)
AF:
0.0383
AC:
2311
AN:
60358
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.468
Heterozygous variant carriers
0
3304
6609
9913
13218
16522
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1624
3248
4872
6496
8120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0275
AC:
4180
AN:
152134
Hom.:
91
Cov.:
32
AF XY:
0.0260
AC XY:
1933
AN XY:
74368
show subpopulations
African (AFR)
AF:
0.00674
AC:
280
AN:
41516
American (AMR)
AF:
0.0258
AC:
394
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
0.0903
AC:
313
AN:
3468
East Asian (EAS)
AF:
0.000387
AC:
2
AN:
5170
South Asian (SAS)
AF:
0.0407
AC:
196
AN:
4820
European-Finnish (FIN)
AF:
0.0203
AC:
215
AN:
10592
Middle Eastern (MID)
AF:
0.0680
AC:
20
AN:
294
European-Non Finnish (NFE)
AF:
0.0393
AC:
2669
AN:
67988
Other (OTH)
AF:
0.0323
AC:
68
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
219
438
658
877
1096
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
54
108
162
216
270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0376
Hom.:
442
Bravo
AF:
0.0271
Asia WGS
AF:
0.0250
AC:
85
AN:
3478
EpiCase
AF:
0.0440
EpiControl
AF:
0.0490

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
4
not specified (4)
-
-
2
not provided (2)
-
-
1
Hereditary spastic paraplegia (1)
-
-
1
Hereditary spastic paraplegia 5A (1)
-
-
1
Spastic paraplegia (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.058
BayesDel_addAF
Benign
-0.60
T
BayesDel_noAF
Benign
-0.60
CADD
Benign
11
DANN
Benign
0.56
DEOGEN2
Benign
0.18
T
Eigen
Benign
-1.0
Eigen_PC
Benign
-0.89
FATHMM_MKL
Benign
0.13
N
LIST_S2
Benign
0.78
T
MetaRNN
Benign
0.0021
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
-0.83
N
PhyloP100
0.78
PrimateAI
Benign
0.19
T
PROVEAN
Benign
1.7
N
REVEL
Benign
0.13
Sift
Benign
0.71
T
Sift4G
Benign
1.0
T
Varity_R
0.029
gMVP
0.15
Mutation Taster
=94/6
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs59035258;
hg19: chr8-65527669;
COSMIC: COSV100041529;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.